Apogee Therapeutics, Inc.
APGE2026/9/3 下市- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. 已在 2026/9/3 下市;內部人最後一份 Form 4 在 2026/9/3 申報;2026 年第 2 季末有 294 家機構在 13F 申報持有,市值合計 $93.8 億;大師中只有索羅斯基金管理持有。
SEC 申報
Apogee Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/9/3 | 8-K | 1.022.013.013.035.015.025.039.01 | 2026/9/3 | SEC | 目錄 |
| 2026/8/11 | 8-K | 5.025.07 | 2026/8/11 | SEC | 目錄 |
| 2026/8/10 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/10 | 8-K | 2.029.01 | 2026/8/10 | SEC | 目錄 |
| 2026/6/22 | 8-K | 1.015.077.018.019.01 | 2026/6/18 | SEC | 目錄 |
| 2026/6/22 | 8-K | 1.019.01 | 2026/6/17 | SEC | 目錄 |
| 2026/6/12 | 8-K | 5.07 | 2026/6/9 | SEC | 目錄 |
| 2026/5/27 | 8-K | 1.017.019.01 | 2026/5/26 | SEC | 目錄 |
| 2026/5/27 | 8-K | 7.018.019.01 | 2026/5/27 | SEC | 目錄 |
| 2026/5/11 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/11 | 8-K | 2.029.01 | 2026/5/11 | SEC | 目錄 |
| 2026/4/24 | 8-K | 5.02 | 2026/4/21 | SEC | 目錄 |
| 2026/3/25 | 8-K | 1.019.01 | 2026/3/24 | SEC | 目錄 |
| 2026/3/23 | 8-K | 7.018.019.01 | 2026/3/23 | SEC | 目錄 |
| 2026/3/2 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/3/2 | 8-K | 9.01 | 2026/3/2 | SEC | 目錄 |
| 2026/1/6 | 8-K | 7.018.019.01 | 2026/1/6 | SEC | 目錄 |
| 2025/11/10 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/10 | 8-K | 2.027.019.01 | 2025/11/10 | SEC | 目錄 |
| 2025/10/10 | 8-K | 1.018.019.01 | 2025/10/8 | SEC | 目錄 |
| 2025/8/11 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/11 | 8-K | 2.029.01 | 2025/8/11 | SEC | 目錄 |
| 2025/7/7 | 8-K | 7.018.019.01 | 2025/7/7 | SEC | 目錄 |
| 2025/6/23 | 8-K | 5.07 | 2025/6/17 | SEC | 目錄 |
| 2025/5/12 | 8-K | 2.027.018.019.01 | 2025/5/12 | SEC | 目錄 |
| 2025/5/12 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/3/11 | 8-K | 1.01 | 2025/3/10 | SEC | 目錄 |
| 2025/3/3 | 8-K | 2.027.019.01 | 2025/3/3 | SEC | 目錄 |
| 2025/3/3 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/3 | 8-K | 7.018.019.01 | 2025/2/3 | SEC | 目錄 |
| 2024/12/10 | 8-K | 7.018.019.01 | 2024/12/10 | SEC | 目錄 |
| 2024/12/2 | 8-K | 7.018.019.01 | 2024/12/2 | SEC | 目錄 |
| 2024/11/12 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/12 | 8-K | 2.029.01 | 2024/11/12 | SEC | 目錄 |
| 2024/10/24 | 8-K | 7.019.01 | 2024/10/24 | SEC | 目錄 |
| 2024/8/19 | 8-K | 7.018.019.01 | 2024/8/19 | SEC | 目錄 |
| 2024/8/12 | 8-K | 2.028.019.01 | 2024/8/12 | SEC | 目錄 |
| 2024/8/12 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/6/7 | 8-K | 5.07 | 2024/6/5 | SEC | 目錄 |
| 2024/5/28 | 8-K | 5.027.019.01 | 2024/5/24 | SEC | 目錄 |
| 2024/5/15 | 8-K | 7.019.01 | 2024/5/15 | SEC | 目錄 |
| 2024/5/13 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/13 | 8-K | 2.029.01 | 2024/5/13 | SEC | 目錄 |
| 2024/3/25 | 8-K | 7.019.01 | 2024/3/25 | SEC | 目錄 |
| 2024/3/5 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/3/5 | 8-K | 7.019.01 | 2024/3/5 | SEC | 目錄 |
| 2024/3/5 | 8-K | 2.027.019.01 | 2024/3/5 | SEC | 目錄 |
| 2023/11/13 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/13 | 8-K | 2.029.01 | 2023/11/13 | SEC | 目錄 |
| 2023/8/28 | 10-Q | – | 2023/6/30 | SEC | 目錄 |